Butylated hydroxytoluene and N-acetylcysteine attenuates tumor necrosis factor-α (TNF-α) secretion and TNF-α mRNA expression in alveolar macrophages from human lung transplant recipients in vitro

Transplantation

Volumn 66, Issue 3, 1998, Pages 364-369

  Hultén, Lillemor Mattsson ^a   Lindmark, Helena ^a   Scherstén, Henrik ^b   Wiklund, Olov ^a   Nilsson, Folke N ^b   Riise, Gerdt C ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BUTYLCRESOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG TRANSPLANTATION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0032529475     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00014     Document Type: Article

References (27)

1. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9: 317.
2. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269(14): 1829.
3. Toborek M, Barger SW, Mattson MP, McClain CJ, Hennig B. Role of glutathione redox cycle in TNF-alpha-mediated endothelial cell dysfunction. Atherosclerosis 1995; 117: 179.
4. Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47(3): 564.
5. Magnan A, Mege JL, Reynaud M, et al. Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients: Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med 1994; 150(3): 684.
6. Baz MA, Tapson VF, Roggli VL, Trigt PV, Piantadosi CA. Glutathione depletion in epithelial lining fluid of lung allograft patients. Am J Respir Crit Care Med 1996; 153: 742.
7. Mendez C, Garcia I, Maier RV. Antioxidants attenuate endotoxin-induced activation of alveolar macrophages. Surgery 1995; 118: 412.
8. Redondo P, Subira ML. N-acetylcysteine inhibits production of tumor necrosis factor α and interleukin-1β. Arch Intern Med 1996; 156: 1238.
9. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arteriosclerosis 1991; 11: 15.
10. Bridgeman MME, Marsden M, MacNee W, Flenley DC, Ryle AP. Cysteine and glutathione concentration in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 1991; 46: 39.
11. Schreck R, Rieber P, Bauerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10: 2247.
12. Andersen LW, Thus J, Kharazmi A, Rygg I. The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 1995; 10(1): 21.
13. Linden M, Wieslander E, Larsson K, Eklund A, Brattsand R. Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers. Eur Respir J 1988; 1: 645.
14. Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995; 152: 1055.
15. Ruse GC, Schersten H, Nilsson FN, Ryd W, Andersson B. Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL: association with acute rejection in lung transplant recipients. Chest 1996; 110: 89.
16. Ruse GC, Kjellström C, Ryd W, et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J 1997; 10: 1742.
17. Yousem SA, Berry G, Brunt E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9: 593.
18. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717.
19. Goossens V, Grooten J, De Vos K, Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8115.
20. Slakey DP, Roza AM, Pieper GM, Johnson CP, Adams MB. Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy. Transplantation 1993; 56: 1305.
21. Mayer M, Noble M. N-Acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994; 91: 7496.
22. Collart Ma, Bauerle P, Vassali P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 1990; 10: 1498.
23. Ferran C, Millan MT, Csizmadia V, et al. Inhibition of NF-κB by pyrridoline dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun 1995; 214: 212.
24. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 2005.
25. Arouma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593.
26. Dent G, Rabe KF, Magnussen H. Augmentation of human neutrophil and alveolar macrophage LTB4 production by N-acetylcysteine: role of hydrogen peroxide. Br J Pharmacol 1997; 122(4): 758.
27. Oddera S, Silvestri M, Sacco O, Eftimiadi C, Rossi GA. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J Lab Clin Med 1994; 124(2): 293.